$16.13
-0.99-5.78%
al cierre: Nov 20, 4:00 PM EST
$16.69
0.563.47%
After hour: Nov 20, 6:19 PM EST
The average analyst price target for Structure Therapeutics is $98.40, 489.6% above the current price. Of 15 analysts, 15 rate it Buy. Targets range from $65 to $140. The latest change came on Aug 7, 2026, when Citigroup lowered its price target on Structure Therapeutics from $100 to $97 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months
